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 Peter Hotez and colleagues, in a new analysis in  PLoS Medicine , throw down a compelling 
challenge to the global health 
community to intensify its response 
to the neglected tropical diseases. 
The authors discuss opportunities 
for integrating neglected disease 
control with interventions against 
the “big three,” namely, HIV/AIDS, 
tuberculosis, and malaria [1]. They 
highlight 13 neglected tropical 
diseases: seven helminthic infections 
(e.g., schistosomiasis), three vector-
borne protozoan infections (e.g., 
lymphatic ﬁ lariasis), and three bacterial 
infections (e.g., trachoma). The main 
geographic focus of these diseases is 
sub-Saharan Africa.
 In the last decade, the world 
has witnessed the establishment of 
numerous global partnerships for 
health that address some of the 
grandest challenges, speciﬁ cally the big 
three, child and maternal mortality, 
and micronutrient deﬁ ciencies. These 
new partnerships have succeeded in 
substantially raising the proﬁ les of 
those health problems, generating 
unprecedented ﬁ nancial resources, 
and improving the technical means 
to tackle them. The global health 
partnerships and additional resources 
provide leverage to attain health- 
and poverty-related international 
development targets, such as the 
Millennium Development Goals.
 In sharp contrast, advocacy to 
increase public awareness of and 
response to the neglected tropical 
diseases has been far less evident. This 
lack of advocacy can be attributed 
to the diseases’ primary impact on 
the poorest of the poor in rural 
and deprived urban settings, the 
underestimation of their public 
health and economic signiﬁ cance, 
and the lack of coordinated research 
and control efforts. How can this 
unacceptable situation be changed? 
Hotez and colleagues provide some 
bold thoughts for a way forward. 
Building on several recent publications 
[2–5], Hotez et al.’s contribution is 
the most complete review of the issues 
to date. It has the potential to bring 
the neglected tropical diseases into a 
global health focus with the necessary 
attention on partnership building to 
facilitate integration of chemotherapy-
based morbidity control.
 Putting Neglected Tropical 
Diseases on the Political Radar 
Screen
 From global health and development 
perspectives, two issues in Hotez 
and colleagues’ analysis are worth 
highlighting. First, the authors have 
made a laudable attempt, using a 
diversity of recent data sources, to 
update the annual number of deaths 
and the disease burden—expressed in 
disability-adjusted life years (DALYs) 
lost—due to the neglected tropical 
diseases. Their new estimates are 
534,000 deaths per year and 56.6 
million DALYs lost. These estimates 
are more than 3-fold higher than 
those put forward in the annex 
tables of the World Health Report 
2004 (deaths, 143,000; burden, 17.7 
million DALYs) [6]. Yet, the true 
burden of the neglected tropical 
diseases is likely to be much higher. 
For example, a recent meta-analysis 
for schistosomiasis suggests that the 
burden of this disease might be several-
fold higher than the previous estimate 
[7]. In addition, no estimates are 
currently available for several other 
neglected tropical diseases, such as 
food-borne trematodiasis, although 
they affect millions of people, are 
associated with severe morbidity if left 
untreated, and are emerging due to 
exponential growth of aquaculture 
(inland freshwater ﬁ sh production) 
development [8,9].
 Second, the article stresses the 
important, albeit largely overlooked, 
issue of geographic overlap of the 
neglected tropical diseases, which 
emphasizes that coinfections are 
pervasive. Recent cross-sectional surveys 
conﬁ rmed that polyparasitism is the 
norm rather than the exception in the 
developing world [10–12]. However, 
surprisingly few studies have made an 
attempt to investigate underlying risk 
factors that govern this phenomenon, 
or to demonstrate associations 
between multiple bacterial/parasitic 
infections and health outcomes. Such 
associations would prompt an interest 
in deeper deterministic understanding 
of the pathways from coinfection to 
comorbidity, and an interest in how to 
reduce disease risk.
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 Crosstalk between Neglected 
Tropical Diseases and the Big 
Three
 Hotez and colleagues summarize 
an emerging body of literature that 
emphasizes the crosstalk between 
the neglected tropical diseases and 
the big three. For example, recent 
studies suggest that helminthic 
infections may be associated with an 
elevated incidence rate of malaria, 
and may worsen clinical outcomes 
of malaria. Although this topic is in 
its infancy, there is a pressing need 
to further our understanding of this 
kind of interaction. At a fundamental 
level, polyparasitisms represent a 
major opportunity for a deeper 
understanding of the physiology of 
homeostatic balance of a host organism 
harboring multiple bacterial and/or 
parasitic infections concurrently. At 
a more pragmatic level, it has been 
suggested that regular deworming 
might have ancillary beneﬁ ts for 
malaria control and vaccine efﬁ cacies 
[2,13].
 The Proposal: Integrated 
Chemotherapy
 It makes sense to integrate 
interventions for multiple diseases 
when those interventions share 
a common technical approach, a 
common target population, and a 
collectively high disease burden. 
Integrating interventions against 
multiple diseases is the basis of the 
cost-effective success of the Expanded 
Program on Immunization, and, more 
recently, of the Integrated Management 
of Childhood Illness [14]. Hotez 
and colleagues propose a pro-poor 
health policy and strategy that exploits 
a similar approach to integration. 
They suggest large-scale deployment 
of just four safe, efﬁ cacious, and 
orally administered drugs, i.e., 
albendazole, azithromycin, ivermectin, 
and praziquantel, which will target 
over 90% of the neglected disease 
burden and will result in additional 
health beneﬁ ts. Further support 
for this integrated chemotherapy 
approach is already in place through 
donations of the required drugs by 
major pharmaceutical companies or 
procurement of the drugs at relatively 
low costs.
 Of course, there are many tactical 
issues to be addressed concerning this 
strategy of integrated chemotherapy-
based control. What are the most 
efﬁ cient and cost-effective means 
to rapidly identify or map areas at 
highest risk of coinfections? Will the 
approach be effective across a diversity 
of epidemiological and sociocultural 
settings? How do we tailor integrated 
chemotherapy for speciﬁ c age groups? 
What are the most appropriate 
time intervals, delivery systems, and 
monitoring and evaluation systems, 
especially for drug interactions, 
compliance, and development and 
spread of resistance? How do we move 
from morbidity control to transmission 
containment?
 The Way Forward: Thinking 
Beyond Integrated Chemotherapy
 Failure to address this collective burden 
of disease, now that an integrated 
approach seems feasible, will result in it 
moving steadily up the ranking into the 
top three once the impact of current 
global health partnerships starts to 
register. We will have to deal with the 
burden sooner or later, so why not now 
so this effort can take advantage of the 
economies of scale that occur during 
national scale up of responses to the 
big three? Hotez and colleagues have 
made a strong case to act, and have 
sketched a strategic approach. Now an 
agenda needs to be developed to map 
out the way forward. Such an agenda 
will need to wrestle not just with the 
challenge of integrating interventions 
into an appropriately designed package 
but also with integrating that package 
into appropriate delivery systems. A 
growing realization in the context of 
how the health-related Millennium 
Development Goals can be achieved, 
especially in sub-Saharan Africa, is the 
need for strengthening health systems 
[15–18]. The January 2006 Stockholm 
meeting, “Malaria and Neglected 
Tropical Diseases Quick-Impact 
Initiative,” could serve as a forum for 
discussions on how to take Hotez and 
colleagues’ proposal forward. The 
discussions will need to bear in mind 
the guiding principles stemming 
from last year’s Paris Declaration on 
Aid Effectiveness (http:⁄⁄www.oecd.
org/dataoecd/11/41/34428351.pdf) 
and the High-Level Forum on the 
Health Millennium Development Goals 
to work toward systemic approaches 
that are aligned and harmonized with 
locally owned national programs, 
and thereby point the way for truly 
integrated and more sustainable 
solutions in the years that lie ahead.  
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